Sleep-Time Blood Pressure: Prognostic Value and Relevance as a Therapeutic Target for Cardiovascular Risk Reduction
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Correlation between blood pressure (BP) level and target organ damage, cardiovascular disease (CVD) risk, and long-term prognosis is greater for ambulatory BP monitoring (ABPM) than clinical BP measurements. Nevertheless, the latter continue to be the "gold standard" to diagnose hypertension, assess CVD risk, and evaluate hypertension treatment. Independent ABPM studies have found that elevated sleep-time BP is a better predictor of CVD risk than either the awake or 24-h BP mean. A major limitation of all previous ABPM-based prognostic studies is the reliance only upon a single baseline profile from each participant at the time of inclusion, without accounting for potential changes in the level and pattern of ambulatory BP thereafter during follow-up. Accordingly, impact of the alteration over time, i.e., during long-term follow-up, of specific features of the 24-h BP variation on CVD risk has never been properly investigated. We evaluated the comparative prognostic value of (i) clinic and ambulatory BP; (ii) different ABPM-derived characteristics, e.g., asleep or awake BP mean; and (iii) specific changes in ABPM characteristic during follow-up, mainly whether reduced CVD risk is more related to the progressive decrease of asleep or awake BP. We prospectively studied 3344 subjects (1718 men/1626 women), 52.6 ± 14.5 (mean ± SD) yrs of age, during a median follow-up of 5.6 yrs. Those with hypertension at baseline were randomized to ingest all their prescribed hypertension medications upon awakening or ≥1 of them at bedtime. At baseline, BP was measured at 20-min intervals from 07:00 to 23:00 h and at 30-min intervals at night for 48-h, and physical activity was simultaneously monitored every min by wrist actigraphy to accurately derive awake and asleep BP means. Identical assessment was scheduled annually and more frequently (quarterly) if treatment adjustment was required. Data collected either at baseline or the last ABPM evaluation per participant showed that the asleep systolic BP mean was the most significant predictor of both total CVD events and major CVD events (a composite of CVD death, myocardial infarction, and stroke). Moreover, when the asleep BP mean was adjusted by the awake mean, only the former was a significant independent predictor of outcome in a Cox proportional-hazard model adjusted for sex, age, diabetes, anemia, and chronic kidney disease. Analyses of changes in ambulatory BP during follow-up revealed 17% reduction in CVD risk for each 5 mm Hg decrease in the asleep systolic BP mean (p < .001), independent of changes in any other clinic or ambulatory BP parameter. The increased event-free survival associated with the progressive reduction in the asleep systolic BP mean during follow-up was significant for subjects with either normal or elevated BP at baseline. The ABPM-derived asleep BP mean was the most significant prognostic marker of CVD morbidity and mortality. Most important, the progressive decrease in asleep BP mean, a novel therapeutic target that requires proper patient evaluation by ABPM and best achieved by ingestion of at least one hypertension medication at bedtime, was the most significant predictor of event-free survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pickering, T. G., Hall, J. E., Appel, L. J., Falkner, B. E., Graves, J., Hill, M. N., Jones, D. W., Kurtz, T., Sheps, S. G., & Roccella, E. J. (2005) · Circulation · doi:10.1161/01.cir.0000154900.76284.f6 · Cited by 3,985
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598 · cited 4×
“We, thus, conclude that the actual controversy on the possible J-shaped relation with CVD risk, described so far only for clinic BP determined in patients presumably treated in the morning (Appel et al., 2010; Bangalore et al., 2010; Cushman et al., 2010; Irie et al., 1993; Okumura et al., 2005; Voko et al., 1999), mi…”
BackgroundInfluentialPickering, T. G., Hall, J. E., Appel, L. J., Falkner, B. E., Graves, J., Hill, M. N., Jones, D. W., Kurtz, T., Sheps, S. G., & Roccella, E. J. (2005) · Hypertension · doi:10.1161/01.hyp.0000150859.47929.8e · Cited by 2,051
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Cardiology in Review · doi:10.1097/01.crd.0000380842.14048.7e · Cited by 1,600
Staessen, J. A. (1999) · JAMA · doi:10.1001/jama.282.6.539 · Cited by 1,592
Circadian variation and triggers of onset of acute cardiovascular disease.
Muller, J. E., Tofler, G. H., & Stone, P. H. (1989) · Circulation · doi:10.1161/01.cir.79.4.733 · Cited by 1,426
Kario, K., Pickering, T. G., Umeda, Y., Hoshide, S., Hoshide, Y., Morinari, M., Murata, M., Kuroda, T., Schwartz, J. E., & Shimada, K. (2003) · Circulation · doi:10.1161/01.cir.0000056521.67546.aa · Cited by 1,250 · cited 9×
“Results of the Japanese study by Kario et al. (2003), however, seem to be inconsistent with their reported higher prevalence of events among patients with a rising BP pattern in the same database (Kario et al., 2001).”
BackgroundMethodResultInfluentialDolan, E., Stanton, A., Thijs, L., Hinedi, K., Atkins, N., McClory, S., Hond, E. D., McCormack, P., Staessen, J. A., & O’Brien, E. (2005) · Hypertension · doi:10.1161/01.hyp.0000170138.56903.7a · Cited by 1,227 · cited 8×
“…prospective studies have reported that the asleep BP mean is a better predictor of CVD events than the awake or 24-h BP mean (Ben-Dov et al., 2007; Boggia et al., 2007; Bouhanick et al., 2008; Dolan et al., 2005; Fagard et al., 2008; Fan et al., 2010; Kikuya et al., 2005; Minutolo et al., 2011).”
BackgroundResultInfluentialPrognostic Value of Ambulatory Blood-Pressure Recordings in Patients with Treated Hypertension
Clement, D. L., De Buyzere, M. L., De Bacquer, D. A., de Leeuw, P. W., Duprez, D. A., Fagard, R. H., Gheeraert, P. J., Missault, L. H., Braun, J. J., Six, R. O., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022273 · Cited by 1,085 · cited 4×
“However, the number of subjects participating in our study was considerably greater than most other published trials on the prognostic value of ABPM (Clement et al., 2003; Eguchi et al., 2008; Perloff et al., 1983; Salles et al., 2008; Verdecchia et al., 1994).”
BackgroundResultInfluentialPrognostic accuracy of day versus night ambulatory blood pressure: a cohort study
Boggia, J., Li, Y., Thijs, L., Hansen, T. W., Kikuya, M., Björklund-Bodegård, K., Richart, T., Ohkubo, T., Kuznetsova, T., Torp-Pedersen, C., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61538-4 · Cited by 887 · cited 8×
“…prospective studies have reported that the asleep BP mean is a better predictor of CVD events than the awake or 24-h BP mean (Ben-Dov et al., 2007; Boggia et al., 2007; Bouhanick et al., 2008; Dolan et al., 2005; Fagard et al., 2008; Fan et al., 2010; Kikuya et al., 2005; Minutolo et al., 2011).”
BackgroundResultInfluential
Cited by
Daskalopoulou, S. S., Rabi, D. M., Zarnke, K. B., Dasgupta, K., Nerenberg, K., Cloutier, L., Gelfer, M., Lamarre-Cliche, M., Milot, A., Bolli, P., et al. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.02.016 · Cited by 684
Hermida, R. C., Ayala, D. E., Mojón, A., & Fernández, J. R. (2013) · Chronobiology International · doi:10.3109/07420528.2012.701127 · Cited by 203
Self-citationChronotherapy With Low-Dose Aspirin for Prevention of Complications in Pregnancy
Ayala, D. E., Ucieda, R., & Hermida, R. C. (2013) · Chronobiology International · doi:10.3109/07420528.2012.717455 · Cited by 203
“…recently documented that the progressive reduction in asleep BP mean, a novel therapeutic target best achieved with bedtime hypertension therapy (Hermida et al., 2011a, 2013b; Portaluppi & Smolensky, 2010; Smolensky et al., 2010), is the most significant predictor of cardiovascular event-free…”
BackgroundInfluentialSelf-citationSmolensky, M. H., Hermida, R. C., Reinberg, A., Sackett-Lundeen, L., & Portaluppi, F. (2016) · Chronobiology International · doi:10.1080/07420528.2016.1184678 · Cited by 197
Self-citationFabbian, F., Smolensky, M. H., Tiseo, R., Pala, M., Manfredini, R., & Portaluppi, F. (2013) · Chronobiology International · doi:10.3109/07420528.2012.715872 · Cited by 147
Ayala, D. E., Hermida, R. C., Mojón, A., & Fernández, J. R. (2013) · Chronobiology International · doi:10.3109/07420528.2012.701455 · Cited by 87
“…have found that the sleeptime BP mean is a better predictor of CVD events than the awake or 24-h BP mean (Ben-Dov et al., 2007; Boggia et al., 2007; Bouhanick et al., 2008; Dolan et al., 2005; Fagard et al., 2008; Fan et al., 2010; Hermida et al., 2011b, 2012a, 2013a, 2013e; Kikuya et al., 2005).”
BackgroundInfluentialSelf-citationHermida, R. C., Ríos, M. T., Crespo, J. J., Moyá, A., Domínguez-Sardiña, M., Otero, A., Sánchez, J. J., Mojón, A., Fernández, J. R., Ayala, D. E., et al. (2013) · Chronobiology International · doi:10.3109/07420528.2012.701460 · Cited by 48
“…in end-organ injury and CVD events (Astrup et al., 2007; Boggia et al., 2007; Brotman et al., 2008; Dolan et al., 2005; Eguchi et al., 2008; Hermida et al., 2003, 2011b, 2012a, 2013a, 2013e, 2013f; Manfredini et al., 2004; Nakano et al., 1998; Ohkubo et al., 2002; Portaluppi & Lemmer,…”
BackgroundMethodResultInfluentialSelf-citation
Metadata
- Authors
- Hermida, R. C., Ayala, D. E., Fernández, J. R., & Mojón, A.
- Venue
- Chronobiology International
- Publisher
- Informa UK Limited
- Published
- 2012-10-25
- Volume
- 30
- Issue
- 1-2
- Pages
- 68-86
- ISSN
- 0742-0528 (ISSN-L)
- 1525-6073
- OpenAlex
- W2088062541
- Cited by
- 99
- References
- 18
- FWCI
- 10.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.